Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

1.380 +0.010 (+0.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pasithea Therapeutics Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Pasithea Therapeutics Leads Healthcare Buzz Surge As Cancer Trial Clears Safety Hurdle, Moves To Next Dosing Cohort
The decision was based on safety data from three patients in Cohort 5, with no dose-limiting toxicities reported. 
Via Stocktwits
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Most active stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session. 
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump
Via Benzinga
Exposures Fossil Fuels
Which stocks are moving before the opening bell on Thursday?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Dow Tumbles Over 800 Points; US Inflation Rate Falls In March
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Thursday's session: top gainers and losers
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Thursday's session: gap up and gap down stocks
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Which stocks are moving before the opening bell on Thursday?
Wondering what's happening in Thursday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
These stocks are moving in today's after hours session
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Crude Oil Down 2%; ISM Services PMI Falls In January
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Surges Over 250 Points; Accenture Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
Via Benzinga
Exposures Fossil Fuels
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
Via Benzinga
Why Is Pasithea Therapeutics Stock Surging On Thursday?
Pasithea Therapeutics reports encouraging early Phase 1 data for PAS-004, showing no adverse events or toxicities. The trial highlights safety, tolerability, and preliminary efficacy in patients with... 
Via Benzinga
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q2 2024
Pasithea Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023
Pasithea Therapeutics just reported results for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.